Transient hepatitis

Česká verze

Authors: P. Laššuthová; Z. Petrová; P. Turek
Authors place of work: Transfúzní oddělení, Fakultní Thomayerova nemocnice, Praha
Published in the journal: Transfuze Hematol. dnes,14, 2008, No. 2, p. 90-91.
Category: Souhrnné práce, původní práce, kazuistiky

Summary

In the paper we present occurence of Hepatitis B surface antigenemia in a blood donor after immunization with first dose of recombinant vaccine Engerix B. Antigenemia was detected by common diagnostic methods. The positive result was on D+2. Control tests on D+16 revealed negative results. The blood donor was not in a risk for Hepatitis B infection. Therefore, we conclude, that the antigenemia occured as a result of vaccination. This paper supports the relevance of the new Guidelines of Society for Transfusion Medicine, where is recommended, that blood donors should defer from donation for one month after vaccination against Hepatitis B.

Key words:
HBsAg, antigenemia, blood donation

Zdroje

1. Kloster B, Kramer R, Eastlund T, Grossman B, Zarvan B. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995; 35 : 475–477.

2. Seed CR, Lee JF, Maloney R, DiRosso A, Cobain TJ. Hepatitis B surface antigenemia in blood donors after vaccination. Transfusion 1996; 36 : 386.

3. Dow BC, Yates P, Galea G, Munro H, Buchanan I, Ferguson K. Hepatitis B vaccinees may be mistaken fo confirmed hepatitis B surface antigen-positive blood donors. Vox Sanguinis 2002; 82 : 15–17.

4. www. transfuznispolecnost.cz/doc/postupy.

5. www.redcross.org/services/biomed/0.1082.0 557 00.html.